is there a tirzepatide shortage The FDA has declared an end to the two-year of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes drug Mounjaro — meaning that far more people could FDA declares Mounjaro, Zepbound shortage

In April 2026, the primary patents for semaglutide expired, a development that may facilitate the entry of generic products into the market and influence the medications price and accessibility

Stopping Abilify suddenly may lead to withdrawal symptoms

Which is why MRC's holistic approach to weight loss supports weight loss in the short and long term

Patients with thyroid conditions need providers who understand the relationship between GLP-1 medications and thyroid function

Even at 5mg/mL, 0.05mg requires just 1 unit, the absolute minimum meaningful mark on the syringe

Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ et al (2019) Glucagon-like peptide 1 (GLP-1)